M2AS34 logo

Masimo BOVESPA:M2AS34 Stock Report

Last Price

R$21.00

Market Cap

R$49.5b

7D

0%

1Y

34.6%

Updated

19 Nov, 2024

Data

Company Financials +

M2AS34 Stock Overview

Develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. More details

M2AS34 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance1/6
Financial Health4/6
Dividends0/6

Masimo Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Masimo
Historical stock prices
Current Share PriceUS$21.00
52 Week HighUS$25.24
52 Week LowUS$15.46
Beta0.97
11 Month Change-1.69%
3 Month Change-5.23%
1 Year Change34.62%
33 Year Changen/a
5 Year Changen/a
Change since IPO-46.01%

Recent News & Updates

Recent updates

Shareholder Returns

M2AS34BR Medical EquipmentBR Market
7D0%-1.6%-0.4%
1Y34.6%16.0%-2.2%

Return vs Industry: M2AS34 exceeded the BR Medical Equipment industry which returned 16% over the past year.

Return vs Market: M2AS34 exceeded the BR Market which returned -2.2% over the past year.

Price Volatility

Is M2AS34's price volatile compared to industry and market?
M2AS34 volatility
M2AS34 Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.1%
Market Average Movement4.4%
10% most volatile stocks in BR Market8.5%
10% least volatile stocks in BR Market2.2%

Stable Share Price: M2AS34's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine M2AS34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19893,800Michelle Brennanwww.masimo.com

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions.

Masimo Corporation Fundamentals Summary

How do Masimo's earnings and revenue compare to its market cap?
M2AS34 fundamental statistics
Market capR$49.50b
Earnings (TTM)R$451.83m
Revenue (TTM)R$11.74b

109.6x

P/E Ratio

4.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
M2AS34 income statement (TTM)
RevenueUS$2.04b
Cost of RevenueUS$1.02b
Gross ProfitUS$1.02b
Other ExpensesUS$943.80m
EarningsUS$78.60m

Last Reported Earnings

Sep 28, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.47
Gross Margin50.05%
Net Profit Margin3.85%
Debt/Equity Ratio52.8%

How did M2AS34 perform over the long term?

See historical performance and comparison